USD 20.86 billion
Report ID:
SQMIG35D2068 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
65
|Figures:
78
Global Clinical Trials Support Services Market size was valued at USD 20.86 billion in 2022 and is poised to grow from USD 22.42 billion in 2023 to USD 39.99 billion by 2031, at a CAGR of 7.50% during the forecast period (2024-2031).
Clinical testing, assay design, and support services for clinical trials are all very helpful. It also includes duties including securing and storing research medications, safeguarding clinical test sites, calculating drug dosages, and managing kits.
Clinical test support services, which include clinical test site help, obtaining and storing study drugs, blinding of study drugs, patient recruitment, coordination, and reconciliation of returned pharmaceuticals, provide the preclinical foundation and research. Significant changes were made to the clinical trial industry in 2021.
Numerous clinical trials that had been postponed owing to the pandemic were restarted with the development of COVID-19 vaccines. There are many unmet demands for the creation of novel pharmaceuticals for the treatment, which necessitates carrying out clinical trials. This is due to the increased prevalence of chronic, infectious, and tropical diseases in emerging nations.
One of the key elements that has contributed to the industry's clinical trials support services sector's revenue growth post-pandemic is the use of virtual clinical trials. In order to streamline their clinical research services, an increasing number of clinical research firms are putting their attention on the deployment of virtual technology.
US Clinical Trials Support Services Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 20.86 billion
Largest Segment
Fastest Growth
phase I
Growth Rate
7.50% CAGR
To get more reports on the above market click here to Buy The Report
The clinical trials support market is segmented into phases, indication and sponsor. The Clinical Trials Support Services Market is divided into four phases: phases I, II, III, and IV. The Clinical Trials Support Services Market is divided into categories for autoimmune/inflammation, oncology, diabetes, cardiovascular, and others based on indication. The Clinical Trials Support Services Market is divided into pharmaceutical and biopharmaceutical businesses, medical device companies, and other companies based on the sponsor. Based on Region Clinical Trials Support Services Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Clinical Trials Support Services Market Analysis by Phases
The market is divided into four phases: phases I, II, III, and IV, with phases III accounting for the biggest market share. There are a number of reasons why Phase III trials are the most expensive and have the largest subject populations. This increases interest in the phase III segment.
Clinical Trials Support Services Market Analysis by Indication
The market is divided into Autoimmune/Inflammation, Oncology, Diabetes, Cardiovascular, and Others based on indication. The category for oncology is anticipated to have the highest CAGR during the projection period. The factors driving the pharmaceutical industry's substantial spending on the preclinical and clinical development of cancer therapeutic items are boosting demand for the oncology market.
To get detailed analysis on other segments, Request For Free Sample Report
On the basis of region, Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA).As the majority of the pharmaceutical companies in the United States do the majority of their business in this region, North America dominated the global market in 2021 with the greatest share of 50.4%. Due to the large number of clinical studies being undertaken in the area, this market is most likely to expand. Government funding for clinical trials and large R&D investments are furthering the market's expansion. The expansion of the market in North America has been attributed to the existence of significant CROs that provide clinical trial support services and multinational pharmaceutical and biopharmaceutical companies that make significant expenditures in clinical research. The fastest-growing geographical market over the projection period is expected to be Asia Pacific. The APAC market is driven by a growing patient population, easy administrative compliance, and low cost.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Clinical Trials Support Services Market Drivers
High Investment to Develop Medical Infrastructure to Bolster Market Growth
Clinical Trials Support Services Market Restraints
Suspended R&D to Hinder Market Growth
Request Free Customization of this report to help us to meet your business objectives.
Market competition for clinical trials support services is average. The main methods used by players to establish and expand their presence in the clinical trial support services market include growing product launches, partnerships, collaborations, agreements, and market expansions. Alcura Health, Charles River Laboratories, Laboratory Corporation of America Holdings (Covance Inc.), Eurofins Scientific, ICON PLC, Parexel International, PPD Inc., and WuXi PharmaTech are some of the main companies in the market.
Clinical Trials Support Services Market Top Player's Company Profiles
Clinical Trials Support Services Market Recent Developments
SkyQuest’s ABIRAWA (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, The increased uptake of cutting-edge medical technologies and the expanding demand for novel pharmaceuticals are driving up demand for the clinical trials sector. Additionally, the high costs and substantially lower approval rates of the medication development process make it exceedingly dangerous for pharmaceutical and biotechnology companies, which restricts the market growth for clinical trials. As a result, contract research organisations (CROs) are increasingly being used to conduct clinical trials, which allows sponsors to focus primarily on the development of new drugs and improves the prognosis for the market. Increased prevalence of infectious and tropical diseases in the region, along with high unmet clinical trial demand in developing nations, are driving the market. The demand for research and development in pharmaceutical businesses to create novel molecules is growing as a result of multiple patent expirations.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 20.86 billion |
Market size value in 2031 | USD 39.99 billion |
Growth Rate | 7.50% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
Clinical Trials Support Services Market Recent Developments
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Clinical Trials Support Services Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Trials Support Services Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Trials Support Services Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Trials Support Services Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35D2068
sales@skyquestt.com
USA +1 351-333-4748